The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
Open accessAbstract
Human artificial chromosome (HAC) has several advantages as a gene therapy vector, including stable episomal maintenance that avoids insertional mutations and the ability to carry large gene inserts including the regulatory elements. Induced pluripotent stem (iPS) cells have great potential for gene therapy, as such cells can be generated from the individual's own tissues, and when reintroduced can contribute to the specialized function of any tissue. As a proof of concept, we show herein the complete correction of a genetic deficiency in iPS cells derived from Duchenne muscular dystrophy (DMD) model (mdx) mice and a human DMD patient using a HAC with a complete genomic dystrophin sequence (DYS-HAC). Deletion or mutation of dystrophin in iPS cells was corrected by transferring the DYS-HAC via microcell-mediated chromosome transfer (MMCT). DMD patient- and mdx-specific iPS cells with the DYS-HAC gave rise to differentiation of three germ layers in the teratoma, and human dystrophin expression was detected in muscle-like tissues. Furthermore, chimeric mice from mdx-iPS (DYS-HAC) cells were produced and DYS-HAC was detected in all tissues examined, with tissue-specific expression of dystrophin. Therefore, the combination of patient-specific iPS cells and HAC-containing defective genes represents a powerful tool for gene and cell therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Establishment in culture of pluripotential cells from mouse embryos
Evans, M. J., & Kaufman, M. H. (1981) · Nature · doi:10.1038/292154a0 · Cited by 8,607
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Self-citationpiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009) · Nature · doi:10.1038/nature07864 · Cited by 1,251
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
Raya, Á., Rodríguez-Pizà, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castellà, M., Río, P., Sleep, E., et al. (2009) · Nature · doi:10.1038/nature08129 · Cited by 696
Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene Therapy
Rideout, W. M., Hochedlinger, K., Kyba, M., Daley, G. Q., & Jaenisch, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00681-5 · Cited by 599
Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H., & Ding, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.014 · Cited by 567
Functional skeletal muscle regeneration from differentiating embryonic stem cells
Darabi, R., Gehlbach, K., Bachoo, R. M., Kamath, S., Osawa, M., Kamm, K. E., Kyba, M., & Perlingeiro, R. C. R. (2008) · Nature Medicine · doi:10.1038/nm1705 · Cited by 359
Derivation of engraftable skeletal myoblasts from human embryonic stem cells
Barberi, T., Bradbury, M., Dincer, Z., Panagiotakos, G., Socci, N. D., & Studer, L. (2007) · Nature Medicine · doi:10.1038/nm1533 · Cited by 330
Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice
Tomizuka, K., Yoshida, H., Uejima, H., Kugoh, H., Sato, K., Ohguma, A., Hayasaka, M., Hanaoka, K., Oshimura, M., & Ishida, I. (1997) · Nature Genetics · doi:10.1038/ng0697-133 · Cited by 267
Self-citationInactivation of a Human Kinetochore by Specific Targeting of Chromatin Modifiers
Nakano, M., Cardinale, S., Noskov, V. N., Gassmann, R., Vagnarelli, P., Kandels-Lewis, S., Larionov, V., Earnshaw, W. C., & Masumoto, H. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.001 · Cited by 267
The Cardiomyopathy of Progressive Muscular Dystrophy
PERLOFF, J. K., DE LEON, A. C., & O'DOHERTY, D. (1966) · Circulation · doi:10.1161/01.cir.33.4.625 · Cited by 250
The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle.
Byers, T. J., Kunkel, L. M., & Watkins, S. C. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.2.411 · Cited by 234
Genetic medicines: treatment strategies for hereditary disorders
O'Connor, T. P., & Crystal, R. G. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1829 · Cited by 180
Dystrophin gene transcribed from different promoters in neuronal and glial cells
Chelly, J., Hamard, G., Koulakoff, A., Kaplan, J.-C., Kahn, A., & Berwald-Netter, Y. (1990) · Nature · doi:10.1038/344064a0 · Cited by 179
Hoshiya, H., Kazuki, Y., Abe, S., Takiguchi, M., Kajitani, N., Watanabe, Y., Yoshino, T., Shirayoshi, Y., Higaki, K., Messina, G., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.253 · Cited by 109
Self-citationConstruction of a novel human artificial chromosome vector for gene delivery
Katoh, M., Ayabe, F., Norikane, S., Okada, T., Masumoto, H., Horike, S., Shirayoshi, Y., & Oshimura, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.145 · Cited by 103
Self-citationViral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
Odom, G. L., Gregorevic, P., & Chamberlain, J. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.007 · Cited by 99
Kimura, E., Han, J. J., Li, S., Fall, B., Ra, J., Haraguchi, M., Tapscott, S. J., & Chamberlain, J. S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn151 · Cited by 69
Upping the Ante: Recent Advances in Direct Reprogramming
Müller, L., Daley, G. Q., & Williams, D. A. (2009) · Molecular Therapy · doi:10.1038/mt.2009.72 · Cited by 66
Artificial and engineered chromosomes: non-integrating vectors for gene therapy
Basu, J., & Willard, H. F. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.03.006 · Cited by 57
Using Therapeutic Cloning to Fight Human Disease: A Conundrum or Reality?
Hall, V. J., Stojković, P., & Stojković, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0592 · Cited by 50
Transfer of human artificial chromosome vectors into stem cells
Oshimura, M., & Katoh, M. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60557-3 · Cited by 39
Self-citationKazuki, Y., Hoshiya, H., Kai, Y., Abe, S., Takiguchi, M., Osaki, M., Kawazoe, S. K. Y., Katoh, M., Kanatsu‐Shinohara, M., Inoue, K., et al. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303091 · Cited by 36
Self-citationDystrophin in control and mdx retina
Zhao, J.-E., Uchino, M., Yoshioka, K., Miyatake, M., & Miike, T. (1991) · Brain and Development · doi:10.1016/s0387-7604(12)80123-9 · Cited by 24
Cited by
Satellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Making muscle: skeletal myogenesis in vivo and in vitro
Chal, J., & Pourquié, O. (2017) · Development · doi:10.1242/dev.151035 · Cited by 825
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Induced pluripotent stem cells: the new patient?
Bellin, M., Marchetto, M. C., Gage, F. H., & Mummery, C. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3448 · Cited by 431
Metadata
- Authors
- Kazuki, Y., Hiratsuka, M., Takiguchi, M., Osaki, M., Kajitani, N., Hoshiya, H., Hiramatsu, K., Yoshino, T., Kazuki, K., Ishihara, C., Takehara, S., Higaki, K., Nakagawa, M., Takahashi, K., Yamanaka, S., & Oshimura, M.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 18
- Issue
- 2
- Pages
- 386-393
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2007786482
- Cited by
- 259
- References
- 36
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.